Physician Profile
Mathew R. Meeneghan, M.D.
Unclaimed ProfileAbout Dr. Meeneghan
Mathew R. Meeneghan, M.D. is a healthcare provider in Bastrop, TX specializing in hematology & oncology. Mathew trained at University of Virginia School of Medicine, graduating in 2009. Mathew is also listed as specializing in internal medicine and student in an organized health care education program. According to Medicare claims data, Mathew cared for 2,305 Medicare patients across 129,551 services. The services billed most often include injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use), injection, pembrolizumab, 1 mg, and injection, iron sucrose, 1 mg.
Summarised automatically from public NPI registry and CMS Medicare data. Not written or reviewed by this provider. Claim this profile to replace it — free, and no identity document with a practice or institutional email.
Education & Training
Specialty
Credentials & Licensing
License numbers are what the provider reported to NPPES when the NPI was issued or updated. NPPES does not verify licensure; confirm current standing with the state licensing board.
Medicare information
Exactly as CMS reports it (National Downloadable File, Opt-Out Affidavits, Order & Referring). Not an insurance directory; confirm coverage with the office.
Contact Information
- (512) 308-9024
- Email not available
Practice Locations
3107 HIGHWAY 71 E
Bastrop, TX 78602
Conditions Commonly Evaluated or Treated
Within Hematology and Oncology generally. Availability varies by clinician, training and location — this profile has not been claimed, so nothing here is a personal claim by the provider.
Conditions
Most searched conditions
- Anemia
- Blood clots
- Breast cancer
- Colon cancer
- Iron-deficiency anemia
- Leukemia
- Lung cancer
- Lymphoma
- Prostate cancer
Advanced Cancers
- Cancer That Has Spread
Blood & Lymph Disorders
- Enlarged spleen
- Swollen Lymph Nodes
Blood Cancers
- Multiple Myeloma
- Myelodysplastic Syndrome
Blood Disorders
- Bleeding Disorders
- Blood Clot in Lung
- Blood Clotting Gene Mutation
- Deep vein thrombosis
- Hemochromatosis
- High Platelet Count
- High White Blood Cell Count
- Low Platelets
- Low White Blood Cell Count
- Thick Blood
- Unexplained Bruising
Blood disorders
- Bone Marrow Scarring
- Hemolytic Anemia in Children
- Pre-Myeloma Protein In Blood
- Vitamin B12 deficiency anemia
Bone & Soft Tissue Cancers
- Bone tumors
- Soft-tissue sarcoma
Digestive Cancers
- Esophageal cancer
- Liver cancer
- Pancreatic cancer
- Stomach cancer
Endocrine Cancers
- Thyroid cancer
Endocrine tumors
- Neuroendocrine Tumors
Gastrointestinal cancer
- Anal cancer
- Appendix cancer
- Bile duct cancer
- Gallbladder cancer
General oncology
- Cancer of unknown primary
Genetic Blood Disorders
- Sickle cell disease
- Thalassemia
Gynecologic cancer
- Vulvar cancer
Gynecologic Cancers
- Cervical cancer
- Endometrial cancer
- Ovarian cancer
Head & Neck Cancers
- Oral cancer
Head and neck cancer
- Laryngeal cancer
- Oral cavity cancer
Neurologic Cancers
- Brain tumor
Oncologic emergencies
- High calcium from cancer
Ophthalmologic oncology
- Melanoma of the eye
Skin cancer
- Skin cancer
Skin Cancers
- Melanoma
Urologic Cancers
- Bladder cancer
- Kidney cancer
- Testicular cancer
Procedures & services
Most searched procedures
- Blood transfusion
- Chemotherapy
- Immunotherapy
- Targeted therapy
Biopsies & Diagnostics
- Bone Marrow Biopsy
- Lumbar puncture
- Lymph Node Biopsy
Blood disorder care
- Blood Exchange Transfusion
- Photopheresis
Cancer Therapies
- Hormone Therapy For Cancer
Cancer therapy
- Chemo allergy desensitization
- Oral chemotherapy management
- Radiation oncology consultation
- Spinal chemo injection
Cellular Therapies
- CAR-T Therapy
- Stem Cell Transplant
Consultations
- Cancer Survivorship Care Plan
- Clinical Trial Screening
- Second Opinion For Cancer
Diagnostic testing
- Circulating tumor cell test
Hematology Treatments
- Blood Clot Management
- Plasmapheresis
- PRP Injection
- Therapeutic Blood Draw
Imaging
- PET Scan
Infusions
- Clotting Factor Replacement
- Iron Infusion
- IV fluids
- IVIG Infusion
Interventional oncology
- Radiofrequency ablation
- TACE Chemoembolization
Supportive Cancer Care
- Bone Strengthening Injections For Cancer
- Pain Management For Cancer
- Red Blood Cell Booster Shot
- White Blood Cell Booster Injection
Supportive cancer care
- Cancer nutrition counseling
- Chemo brain treatment
- Cold cap therapy for hair loss
- Fertility Preservation for Teens Before Cancer Treatment
- Hyperbaric oxygen for radiation damage
- Lymphedema Drainage Therapy
- Palliative cancer care
Surgical & Vascular Access
- Chemo port placement
- Chemo port removal
- Draining lung fluid
- Paracentesis
- PICC line placement coordination
Testing & Genetics
- Cancer Genetic Testing
- Cancer Tumor Profiling
- Liquid Biopsy
Vascular access care
- Chemo port check
- Chemo Port Flush And Maintenance
- PICC line dressing change
Procedures Most Often Billed to Medicare
129,551 services · 2,305 patients · 25 distinct codes
| Procedure | Type | Code | Services | Compared with peers |
|---|---|---|---|---|
| Insertion of needle into vein for collection of blood sample | Procedure | 36415 |
1,631 | More often than most peers in Hematology & Oncology |
| Injection, pembrolizumab, 1 mg | Drug given | J9271 |
16,000 | More often than most peers in Hematology & Oncology |
| Injection, iron sucrose, 1 mg | Drug given | J1756 |
15,100 | More often than most peers in Hematology & Oncology |
| Injection, nivolumab, 1 mg | Drug given | J9299 |
14,200 | As often as other peers in Hematology & Oncology |
| Injection, oxaliplatin, 0.5 mg | Drug given | J9263 |
12,900 | As often as other peers in Hematology & Oncology |
| Injection, daratumumab, 10 mg and hyaluronidase-fihj | Drug given | J9144 |
9,900 | As often as other peers in Hematology & Oncology |
| Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Drug given | J0881 |
8,205 | Less often than most peers in Hematology & Oncology |
| Injection, fosaprepitant, 1 mg | Drug given | J1453 |
5,850 | Less often than most peers in Hematology & Oncology |
| Injection, paclitaxel, 1 mg | Drug given | J9267 |
5,484 | As often as other peers in Hematology & Oncology |
| Injection, denosumab, 1 mg | Drug given | J0897 |
3,480 | As often as other peers in Hematology & Oncology |
Source: CMS Medicare public data. Shows how often procedures were billed — not quality of care or patient satisfaction.
Related providers
Connections drawn from the registry and from what providers have told us. A link here is not a referral or an endorsement.
Other cancer specialists at this location 3
Same specialty, same street address — most likely the same department or group.
Also at this address 2
Providers at the same street address. Each files their own registry entry, so a shared practice often appears under several different names.
Trained at University of Virginia School of Medicine 8
Other providers in the same specialty who trained at the same institution.
More connections — 16 related providers in 2 groups
Class of 2009 at University of Virginia School of Medicine 8
Providers who graduated from the same medical school in the same year.
Also performs Insertion of needle into vein for collection of blood sample 8
Providers in TX who bill this service to Medicare most often.
- Quest Diagnostics Clinical Laboratories INC
- Clinical Pathology Laboratories, INC.
- Quest Diagnostics Clinical Laboratories INC
- Laboratory Corporation of America
- Laboratory Corporation of America
- Lone Star Pathology PLLC
- Norman B Frankel Et Al Ptr Medical Clinic of Houston
- The University of Texas Southwestern Medical Center at Dallas
Common questions
What is Mathew R. Meeneghan's specialty?
Mathew R. Meeneghan is a cancer specialist in Bastrop, TX. That is the designation recorded for this NPI in the federal registry, where it is listed as “Hematology & Oncology”.
NPI registry
Where can I find Mathew R. Meeneghan?
Mathew R. Meeneghan is listed at 3107 Highway 71 E, Bastrop, TX 78602. Addresses come from the NPI registry and can lag a move, so confirm before travelling.
NPI registry
How do I contact Mathew R. Meeneghan?
The number on file is (512) 308-9024. Guide.md cannot book appointments or pass on messages — please call the office directly.
NPI registry
What is Mathew R. Meeneghan's NPI number?
Mathew R. Meeneghan's National Provider Identifier is 1467695460. It is issued by the Centers for Medicare & Medicaid Services and is unique and permanent — it does not change if they move practice.
NPI registry
What is Mathew R. Meeneghan's education?
Mathew R. Meeneghan attended University of Virginia School of Medicine, graduating in 2009. This comes from the CMS National Downloadable File.
CMS public data
How long has Mathew R. Meeneghan been practicing?
Mathew R. Meeneghan has 17 years experience. Calculated from a graduation year of 2009, reported in the CMS National Downloadable File.
CMS public data
What is Mathew R. Meeneghan known for?
According to Medicare billing data, Mathew R. Meeneghan performs procedures including insertion of needle into vein for collection of blood sample, alongside routine visits and testing. This reflects Medicare patients only and is billing volume, not a measure of quality.
Medicare claims
Has Mathew R. Meeneghan confirmed this information?
Not yet. This profile is built from public federal data and has not been confirmed by Mathew R. Meeneghan. If this is you, claiming it is free.
Guide.md
Provider data sourced from the NPPES NPI Registry and CMS public datasets. Information is provided for reference and is not medical advice.